# OnCo record crism-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/crism-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "crism-therapeutics" ;
  schema:name "CRISM Therapeutics"@en ;
  schema:alternateName "CRISM Therapeutics Corporation"@en ;
  schema:description "CRISM Therapeutics makes ChemoSeed, small dissolving implants that release chemotherapy slowly into the tissue left behind after a brain tumour is removed. Its first trial is in people having surgery for glioblastoma in the UK."@en ;
  schema:url <https://onco.cc/companies/crism-therapeutics/>, <https://www.crismtherapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.crismtherapeutics.com/>, <https://www.crismtherapeutics.com/regulatory-and-ethical-approval-2/>, <https://www.crismtherapeutics.com/chemoseed/>, <https://clinicaltrials.gov/study/NCT07356973> ;
  schema:addressCountry "GB" ;
  onco:related <https://onco.cc/companies/crispr-therapeutics/> ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/chemotherapy/>, <https://onco.cc/fronts/surgery/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/topoisomerase-inhibitors/> ;
  onco:trials <https://onco.cc/trials/nct07356973/> .